Quetiapine is a generic drug prescribed to treat the symptoms of schizophrenia, bipolar disorder, or depression in some people. Quetiapine has FDA boxed warnings for increased risk of death in adults ...
Quetiapine is suitable for adults. Quetiapine is not licensed for use in children under 18 years of age. However, it may sometimes be prescribed by specialists to treat schizophrenia or mania in ...
It works by altering the levels of certain chemical messengers called neurotransmitters in your brain — in particular, serotonin and dopamine. Although it has a sedative effect, quetiapine isn’t ...
Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium. The ...
Quetiapine is a drug designed to reduce hallucinations and delusions experienced by people with schizophrenia or bipolar disorder. The most common brand name of quetiapine is Seroquel but it’s also ...
Please provide your email address to receive an email when new articles are posted on . Nearly 500 members of the International Parkinson and Movement Disorder Society completed the survey. Quetiapine ...
In June 2005 and December 2006, Medline, the Cochrane Database of Systematic Reviews, ACP Journal Club, Database of Reviews of Effectiveness, Cochrane Controlled Trials Registry, and International ...
Adjunctive CBT vs quetiapine monotherapy led to greater improvements in depressive symptoms. Adding cognitive behavioral therapy (CBT) to quetiapine vs quetiapine alone significantly reduces suicide ...
Nasal esketamine spray is more effective than an extended-release antipsychotic, when both are taken in combination with SSRIs and SNRIs, in patients with depressive episodes that didn’t respond to ...
Are you taking Quetiapine? Are you aware of the dangers of combining Quetiapine with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side ...
May 24, 2007 (San Diego) — A recent study found that among patients in a psychiatric hospital, the atypical antipsychotic quetiapine (Seroquel, AstraZeneca), which is approved for schizophrenia and ...
Quetiapine (Seroquel) was more clinically effective than lithium as a first-line augmentation option in treatment-resistant depression and likely was more cost-effective, a pragmatic multicenter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results